A new feasibility study for B2Gold’s (TSX: BTO; NYSE: BTG) Gramalote open pit project in central Colombia lifts the net ...

Just by adding a cup of black beans per day to their diet, participants in this study reduced chronic low-grade inflammation ...

Life of Project after-tax free cash flow of $1.67 billion at a $2,500 per ounce gold price (“$2,500 Gold Price”) Life of Project after-tax free cash flow of $2.81 billion at the spot gold price of ...

Final analysis of the INTRIGUE trial shows ripretinib offers similar survival rates and better safety compared to sunitinib ...

Nearly three-quarters of older adults with advanced cancer value quality of life over extending survival, according to study ...

GCSE students in England, Wales and Northern Ireland will receive their results on Thursday 21 August.In England, GCSEs are ...

With soaring prices, the time could not be more right to get a gold mine into production. These ASX companies are doing just ...

Nearly 1 in 4 third graders risked being retained under Louisiana's new reading law, but far fewer are likely to be held back ...

A large prospective study shows that robotic-assisted bronchoscopy is safe and effective in reaching lesions in majority ...

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

Ruxolitinib shows sustained efficacy and safety in treating steroid-refractory chronic graft-vs-host disease, outperforming ...

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.